JOURNAL DESCRIPTION
The Medical Radiology and Radiation Safety journal ISSN 1024-6177 was founded in January 1956 (before December 30, 1993 it was entitled Medical Radiology, ISSN 0025-8334). In 2018, the journal received Online ISSN: 2618-9615 and was registered as an electronic online publication in Roskomnadzor on March 29, 2018. It publishes original research articles which cover questions of radiobiology, radiation medicine, radiation safety, radiation therapy, nuclear medicine and scientific reviews. In general the journal has more than 30 headings and it is of interest for specialists working in thefields of medicine¸ radiation biology, epidemiology, medical physics and technology. Since July 01, 2008 the journal has been published by State Research Center - Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency. The founder from 1956 to the present time is the Ministry of Health of the Russian Federation, and from 2008 to the present time is the Federal Medical Biological Agency.
Members of the editorial board are scientists specializing in the field of radiation biology and medicine, radiation protection, radiation epidemiology, radiation oncology, radiation diagnostics and therapy, nuclear medicine and medical physics. The editorial board consists of academicians (members of the Russian Academy of Science (RAS)), the full member of Academy of Medical Sciences of the Republic of Armenia, corresponding members of the RAS, Doctors of Medicine, professor, candidates and doctors of biological, physical mathematics and engineering sciences. The editorial board is constantly replenished by experts who work in the CIS and foreign countries.
Six issues of the journal are published per year, the volume is 13.5 conventional printed sheets, 88 printer’s sheets, 1.000 copies. The journal has an identical full-text electronic version, which, simultaneously with the printed version and color drawings, is posted on the sites of the Scientific Electronic Library (SEL) and the journal's website. The journal is distributed through the Rospechat Agency under the contract № 7407 of June 16, 2006, through individual buyers and commercial structures. The publication of articles is free.
The journal is included in the List of Russian Reviewed Scientific Journals of the Higher Attestation Commission. Since 2008 the journal has been available on the Internet and indexed in the RISC database which is placed on Web of Science. Since February 2nd, 2018, the journal "Medical Radiology and Radiation Safety" has been indexed in the SCOPUS abstract and citation database.
Brief electronic versions of the Journal have been publicly available since 2005 on the website of the Medical Radiology and Radiation Safety Journal: http://www.medradiol.ru. Since 2011, all issues of the journal as a whole are publicly available, and since 2016 - full-text versions of scientific articles. Since 2005, subscribers can purchase full versions of other articles of any issue only through the National Electronic Library. The editor of the Medical Radiology and Radiation Safety Journal in accordance with the National Electronic Library agreement has been providing the Library with all its production since 2005 until now.
The main working language of the journal is Russian, an additional language is English, which is used to write titles of articles, information about authors, annotations, key words, a list of literature.
Since 2017 the journal Medical Radiology and Radiation Safety has switched to digital identification of publications, assigning to each article the identifier of the digital object (DOI), which greatly accelerated the search for the location of the article on the Internet. In future it is planned to publish the English-language version of the journal Medical Radiology and Radiation Safety for its development. In order to obtain information about the publication activity of the journal in March 2015, a counter of readers' references to the materials posted on the site from 2005 to the present which is placed on the journal's website. During 2015 - 2016 years on average there were no more than 100-170 handlings per day. Publication of a number of articles, as well as electronic versions of profile monographs and collections in the public domain, dramatically increased the number of handlings to the journal's website to 500 - 800 per day, and the total number of visits to the site at the end of 2017 was more than 230.000.
The two-year impact factor of RISC, according to data for 2017, was 0.439, taking into account citation from all sources - 0.570, and the five-year impact factor of RISC - 0.352.
Medical Radiology and Radiation Safety. 2025. Vol. 70. № 6
DOI:10.33266/1024-6177-2025-70-6-121-128
S.M. Minin1, Zh.Zh. Anashbaev1, N.V. Novikova1, E.A. Samoilova1,
S.I. Sazonova2, N.V. Salin2, S.M. Korobeinikov3, Yu.B. Lishmanov4,
W.Yu. Ussov1, A.M. Chernyavsky1
The Possibilities of Employing Spect/Ct with 99mtc-MIBI in the Screening of Tumors of the Chest (Lung Cancer, Breast Cancer)
in Patients with Pathology of the Cardiovascular System
1 E.N. Meshalkin National Research Medical Center, Novosibirsk, Russia
2 Scientific Research Institute of Cardiology, Tomsk, Russia
3 Novosibirsk State Technical University, Novosibirsk, Russia
4 National Research Tomsk Polytechnic University, Tomsk, Russia
Contact person: Wladimir Yuryevich Ussov, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. , This email address is being protected from spambots. You need JavaScript enabled to view it.
Summary
Background: It is assumed that with the screening use of SPECT/CT with 99mTc-MIBI in patients with suspected coronary heart disease, this study may also reveal concomitant cancer at the preclinical pre-metastatic stage in patients who have developed lung cancer or breast cancer, so far only at an asymptomatic stage.
Purpose: To evaluate the possibilities of SPECT/CT with 99mTc-MIBI as a screening method for the diagnosis of lung cancer and breast cancer in the mass examination of patients aged 42‒75 years for coronary artery disease.
Material and methods: The study comprised 1127 patients (796 men and 331 women), aged 39‒80 years, who were studied on an outpatient basis in the Department of Radionuclide Therapy and Diagnostics of the NMIC in the period from April 2022 to October 2024. Аn SPECT/CT examination of the myocardium with 99mTc-MIBI was performed during the diagnosis of coronary heart disease, which completely included the chest area, from the lower neck to the top of the abdominal cavity. Patients who, due to the main focus on the detection of coronary heart disease, did not cover the entire chest area were not included in the study. The SPECT was performed in a 64×64 matrix with 180° rotation of the gamma camera detector, 32‒64 projections, and a rotation radius of 35‒40 cm, with a set of at least 50,000 impulses per each. Up to 50 transverse tomographic sections of the heart and chest were reconstructed, taking into account the tissue absorption of 0.12 cm‒1. A visual analysis was performed for the presence of nodular pathology in the lungs with a uptake of 99mTc-MIBI. The tumor blood flow (РКрОп, ml) were calculated as РКрОп = СПНTc-MIBI × (МО / ВbodyWeightof Patient) × 100, where СПН Tc-MIBI is the standardized uptake value of the radiopharmaceutical, and MO is the minute volume of cardiac output, in ml/min, and 100 is the conversion factor for representing the result in the usual units of ml/min/100 g of tissue. According to the uptake of 99mTc-MIBI in the organs and systems of the patient, the radiation dose for SPECT was calculated using the technique and the MIRD software, as well as the radiation ldose provided by X-ray CT of the examined area, in contrast-free mode and with additional intravenous contrast enhancement.
Results: When using SPECT/CT with 99mTc-MIBI for the diagnosis of coronary heart disease, confirmation of the referral diagnosis was obtained as a transient defect of myocardial perfusion in 23 % of the examined patients, and in 7 % as a persistent defect in perfusion. Along with coronary heart disease, 9 patients (8 men, 1 woman) were diagnosed with clinically asymptomatic lung cancer (6 had central lung cancer, 3 had peripheral one) as a nodular formation with pathological absorption of this radiopharmaceutical. 6 patients with lung cancer had relatively low blood flow in the primary tumor node, 14‒25 ml/min/100 g of tissue (on average, 19.5 ± 3.5 ml/min/100 g of tissue). The stage of the disease was as follows: T1N0M0 – in 2, T2N0M0 – in 2, T3N1M0 – in 1, T2N1M1 – in 1. In three out of nine patients with lung cancer, blood flow in the primary node was significantly higher, ranging from 27‒43 ml/min/100 g of tissue (on average, 34.5 ± 6.2 ml/min/100 g of tissue). Their stages of the disease were T2N1M0 – 2 patients, T3N2M1 – 1 patient, which corresponded to the wellknown relationship “high blood flow in the primary tumor ‒ higher probability of metastasis”. Of the women examined, two had clinically asymptomatic breast cancer, T2N0M0 and T1N1M0, which was first detected during this SPECT/CT.
Conclusions: It is reasonable to believe that SPECT/CT of the heart and chest with 99mTc-MIBI can act not only as a highly sensitive marker of myocardial blood flow, providing outpatient diagnosis of coronary heart disease, but also for screening detection of tumor pathology of the chest organs, due to the oncotropy of this radiopharmaceutical, while minimizing radiation exposure to the patient.
Keywords: SPECT/CT, 99mTc-MIBI, coronary heart disease, screening, lung cancer
For citation: Minin SM, Anashbaev ZhZh, Novikova NV, Samoilova EA, Sazonova SI, Salin NV, Korobeinikov SM, Lishmanov YuB, Ussov WYu, Chernyavsky AM. The Possibilities of Employing Spect/Ct with 99mtc-MIBI in the Screening of Tumors of the Chest (Lung Cancer, Breast Cancer) in Patients with Pathology of the Cardiovascular System. Medical Radiology and Radiation Safety. 2025;70(6):121–128. (In Russian). DOI:10.33266/1024-6177-2025-70-6-121-128
References
1. Vazhenin A.V., Novikova S.V., Tyukov Yu.A. Oncoepidemiological Situation in the Russian Federation and in the World Based on the Analysis of Indicators of Leading Malignant Neoplasms of the Population. Menedzher Zdravookhraneniya = Health Care Manager. 2025;3:135-144. doi: 10.21045/1811-0185-2025-3-135-144 (In Russ.). EDN CATZLU.
2. Shlyakhto Ye.V., Baranova Ye.I. The Main Directions for Reducing Cardiovascular Mortality: what Can be Changed Today? Rossiyskiy Kardiologicheskiy Zhurnal = Russian Journal of Cardiology. 2020;25;7:10-18 (In Russ.). doi: 10.15829/1560-4071-2020-3983.
3. Fedorov N.M., Pavlova V.I., Abalkanova M.M., Sinyakov A.G. Dynamics of Incidence and Mortality from Breast Cancer in the Russian Federation and the Tyumen Region for the Period 2019-2023. Tyumenskiy Meditsinskiy Zhurnal = Tyumen Medical Journal. 2024;26;2:26-30. EDN IUWVHY.
4. Bushmanov A.Yu., Kretov A.S., Kalinina M.Yu., Vlasova I.V., Lomteva A.A., Gugina A.A., Tsarev A.N., Denisova Ye.A., Soloreva M.A., Samoylov A.S. Medical Examinations and Psychophysiological Testing of Nuclear Industry Personnel as a Means of Preventing Radiation Accidents. Meditsina Katastrof = Disaster Medicine. 2021;3:20-23 (In Russ.).
5. Gombolevskiy V.A., Barchuk A.A., Laypan A.Sh., Vetsheva N.N., Vladzimirskiy A.V., Morozov S.P. Lung Cancer Screening Using Low-Dose Computed Tomography: Organization and Efficiency. Radiologiya – Praktika = Radiology and Practice. 2018;1;67:28-36 (In Russ.).
6. Ansheles A.A., Sergiyenko V.B. Yadernaya Kardiologiya = Nuclear Cardiology. Moscow, Natsional’nyy Meditsinskiy Issledovatel’skiy Tsentr Kardiologii Publ., 2021. 516 p. (In Russ.).
7. Usov V.Yu., Ryannel’ Yu.Ye., Mikhaylovich Ya.M., Slonimskaya Ye.M., Velichko S.A. Mammascintigraphy: Fundamentals, Protocols, Clinical Application. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Мedical Radiology and Radiation Safety. 1999;44;3:72-82 (In Russ.). EDN MPDAQN.
8. Popova N.S., Novikov S.N., Krzhivitskiy P.I., Zhukova L.A., Krivorot’ko P.V., Artem’yeva A.S., Valitova A.A., Khoroshavina A.A., Chernaya A.V., Bryantseva Zh.V., Akulova I.A., Mikhnin A.Ye., Yaganova T.S., Kanayev S.V. Diagnostic Capabilities of Mammoscintigraphy in Detecting Multicentric and Minimal Breast Cancer of Various Molecular Subtypes. Voprosy Onkologii = Problems in Oncology. 2023;69;4:708-714 (In Russ.). doi:10.37469/0507-3758-2023-69-4-708-714.
9. Stukanov S.L., Usov V.YU., Kolomiyets S.A., Ryannel’ YU.Ye., Velichko S.A., Zyryanov B.N. Single-Photon Emission Computed Tomography with 99mTc-Technetrile in Lung Cancer. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Мedical Radiology and Radiation Safety. 1996;41;6:11-15
(In Russ.). EDN MOVAXT.
10. Minin S.M., Anashbayev Zh.Zh., Samoylova Ye.A., Zheravin A.A., Usov V.Yu., Krasil’nikov S.Ye., Chernyavskiy A.M. Single-Photon Emission Computed Tomography (SPECT/CT) with 99mTc-Technetrile in Staging, Planning External Beam Radiotherapy and Monitoring of Lung Cancer: a Clinical Case and a Case-Addressed Literature Review. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Мedical Radiology and Radiation Safety. 2023;68;5:96–104 (In Russ.). doi: 10.33266/1024-6177-2023-68-5-96-104.
11. Narkevich B.Ya., Kostylev V.A., Levchuk A.V., Dolgushin B.I., Tkachev S.I., Shir’yayev S.V. Radiation Safety in Medical Radiology. Part 2. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Мedical Radiology and Radiation Safety. 2009;54;3:46-57 (In Russ.). EDN TEAELV.
12. Matkevich Ye.I., Sinitsyn V.Ye., Zelikman M.I., Kruchinin S.A., Ivanov I.V. Main Directions of Reducing Radiation Doses to Patients during Computed Tomography. REJR 2018;8;3: 60-73 (In Russ.). doi: 10.21569/2222-7415-2018-8-3-60-73.
13. Gombolevskiy U.A., Chernina V.Yu., Blokhin I.A., Nikolayev A.Ye., Barchuk A.A., Morozov S.P. Main Achievements of Low-Dose Computed Tomography in Lung Cancer Screening. Tuberkulez i Bolezni Legkikh = Tuberculosis and Lung Diseases. 2021;99;1:61-70 (In Russ.). doi: 10.21292/2075-1230-2021-99-1-61-70.
14. Zolotnitskaya V.P. 100 Years of Development of Radionuclide Diagnostics. Study of Pulmonary Microcirculation. Regionarnaya Gemodinamika i Mikrotsirkulyatsiya = Regional Blood Circulation and Microcirculation. 2024;23;4: 139–148
(In Russ.). doi.org/10.24884/1682-6655-2024-23-4-139-148
15. Bereznikov A.V., Shkitin S.O., Tyurin I.Ye. Possibilities of Chest Radiography in Primary Diagnostics of Lung Cancer. Zhurnal Radiologii i Yadernoy Meditsiny = Radiology and Nuclear Medicine. 2024;105;3:149–155 (In Russ.). doi: 10.20862/0042-4676-2024-105-3-149-155.
16. Ladak A.A., Sandhu S., Itrat A. Use of Intravenous Thrombolysis in Acute Ischemic Stroke Management in Patients with Active Malignancies: A Topical Review. J Stroke Cerebrovasc Dis. 2021;30;6:105728. doi: 10.1016/j.jstrokecerebrovasdis.2021.105728.
17. Slart R.H., Bax J.J., van Veldhuisen D.J., van der Wall E.E., Dierckx R.A., Jager P.L. Imaging Techniques in Nuclear Cardiology for the Assessment of Myocardial Viability. Int J Cardiovasc Imaging. 2006;22;1:63-80. doi:10.1007/s10554-005-7514-8 .
18. Medical Advisory Secretariat. Magnetic Resonance Imaging (MRI) for the Assessment of Myocardial Viability: an Evidence-Based Analysis. Ont Health Technol Assess Ser. 2010;10;15: 1-45.
19. Usov V.Yu., Babikov V.Yu., Minin S.M., Sukhov V.Yu., Kostenikov N.A., Luchich M.A., Samoylova Ye.A., Zheravin A.A., Chernyavskiy A.M. Quantitative SPECT of the Brain with 99mTc-Technetrile in Diagnostics, Evaluation of the Effectiveness of Complex Therapy of Low-Grade Gliomas and Prognosis of Patients’ Life. Rossiyskiy Neyrokhirurgicheskiy Zhurnal Im. Professora A.L. Polenova = Russian Neurosurgical Journal Named after Professor A.L. Polenova.. 2023;15;C1:26-27. EDN QGPXKZ.
20. Scopinaro F., Schillaci O., De Vincentis G., Danieli R., Ierardi M, Picardi V, Tavolaro R, Colella AC, Ussov W, Nordling K, Capoferro R.A. A Three Center Study on the Diagnostic Accuracy of 99mTc-MIBI Scintimammography. Anticancer Research. 1997;17;3B:1631-1634. EDN LEJMJT.
21. Zhang S., Liu Y. Diagnostic Performances of 99mTc-Methoxy Isobutyl Isonitrile Scan in Predicting the Malignancy of Lung Lesions: A Meta-Analysis. Medicine (Baltimore). 2016;95;18: e3571. doi: 10.1097/MD.0000000000003571.
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study was carried out as part of State Assignment No. 123030900018-1 of the Russian Ministry of Health.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.07.2025. Accepted for publication: 25.08.2025.